Newsroom | 70803 results

DURHAM, N.C.--(BUSINESS WIRE)--Target RWE and NoviSci, two leaders in evidence generation, today announced they will rebrand as Pedestal Health and Headwater Science. These two distinct companies will work to build a modern evidence-generation engine for life sciences organizations, navigating the most complex and consequential research challenges. Pedestal Health (formerly Target RWE) is a full-service evidence generation partner for life sciences organizations. The company delivers scientific...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s BAXFENDY™ (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood pressure in adults who are not adequately controlled. There are 1.4 billion people worldwide living with hypertension.1 In the US, approximately 50% of patients living with hypertension who are already taking multiple antihypertensive me...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parabilis Medicines today announced a strategic research collaboration with Regeneron Pharmaceuticals, Inc. to discover and develop multiple therapeutic candidates based on Parabilis’s Helicon™ peptide platform, with a particular focus on Antibody-Helicon™ Conjugates (AHCs), a novel class of therapeutics designed to target challenging and historically “undruggable” targets. Helicons are stabilized, cell-penetrant alpha-helical peptides designed to engage intra...

LONDRES, MUNICH et ZURICH--(BUSINESS WIRE)--Le ministère coréen des Sciences et des TIC (MSIT) organisera en juin le Salon mondial de l’emploi postdoctoral InnoCORE 2026, avec des événements prévus à Londres, Munich et Zurich. Cette initiative fait suite au lancement réussi de l’événement à New York, Boston et dans la Silicon Valley en mai 2026. Organisé par le MSIT en collaboration avec le KAIST, le GIST, le DGIST et l’UNIST, ce salon mettra en relation d’excellents chercheurs postdoctoraux du...

LONDON & MÜNCHEN & ZÜRICH--(BUSINESS WIRE)--Das koreanische Ministerium für Wissenschaft und IKT (MSIT) veranstaltet im Juni die InnoCORE Global Postdoctoral Job Fair 2026 mit bevorstehenden Veranstaltungen in London, München und Zürich. Dies folgt auf den erfolgreichen Start der Initiative im Mai 2026 in New York, Boston und im Silicon Valley. Die vom MSIT gemeinsam mit KAIST, GIST, DGIST und UNIST organisierte Jobmesse wird herausragende Postdoktoranden aus aller Welt mit führenden koreanisch...

LONDON & MUNICH & ZURICH--(BUSINESS WIRE)--The Korean government hosts the 2026 InnoCORE Global Postdoctoral Job Fair in London, Munich, and Zurich....

MONTPELLIER, France & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced the appointment of Fred Chereau as Chief Executive Officer (CEO), effective June 1, 2026. Fred brings more than 30 years of leadership and operational experience across the biotechnology, pharmaceutical, and medical devic...

JERSEY CITY, N.J.--(BUSINESS WIRE)--A Organon (NYSE: OGN), empresa global de saúde com a missão de oferecer medicamentos e soluções de impacto para um dia a dia mais saudável, apresentará dados nas áreas de saúde feminina, biossimilares, dermatologia e neurologia no ISPOR 2026, a principal conferência científica global promovida pela International Society for Pharmacoeconomics and Outcomes Research. A conferência, focada em economia da saúde e pesquisa de desfechos, ocorrerá de 17 a 20 de maio...

紐澤西州澤西市--(BUSINESS WIRE)--(美國商業資訊)-- 全球性醫療保健公司Organon (NYSE: OGN)致力於提供具有影響力的藥物和解決方案，以守護大眾日常健康。公司將在國際藥物經濟學與結果研究協會主辦的全球頂尖學術會議ISPOR 2026上發表涵蓋女性健康、生物相似藥、皮膚病學和神經病學領域的多項研究資料。本次大會聚焦衛生經濟學與結果研究，將於2026年5月17日至20日在賓夕法尼亞州費城舉行。 本次共有8篇摘要入選大會展示，相關資料體現Organon致力於立足真實生活經驗生成真實世界證據，可為醫療決策制定提供參考，並改善多個治療領域的健康結果。 Organon研發負責人兼醫療長Juan Camilo Arjona Ferreira, MD表示：「衛生經濟學和結果研究對於確保合適的治療方案嘉惠病患、以及醫療體系長期維持這一服務模式至關重要。在ISPOR 2026上，Organon很榮幸分享關於避孕、皮膚病及神經疾病治療的預算影響、轉診模式和真實世界證據的研究成果，所有研究均以實證為基礎，將病患和醫療執業者視角置於核心位置。」 Organon產品組合將展示的關...

TOKYO--(BUSINESS WIRE)--P-Life Japan Inc. has identified and verified groundbreaking scientific evidence demonstrating the microbial bioassimilation of plastics enabled by its proprietary P-Life technology. Each year, the world produces nearly 400 million tons of plastic, and close to half of it is designed for single use. An estimated 11 million tons end up in the oceans annually, where they can persist for centuries. The challenge has never been simply about recycling — it has been about phys...